Sixty patients presenting for in-patient gynaecological laparoscopic surgery were randomly allocated to receive either diclofenac 75mg (n=20), ketorolac 30mg (n=20) or piroxicam 20mg (n=20) as an intra-muscular injection immediately after induction of anaesthesia. Postoperative visual analogue scores over the first 24 hours, using a 10cm scale, ranged from 3.2-0.5 in the diclofenac group, 2.7-0.85 in the ketorolac group and 2.8-0.5 in the piroxicam group. The scores did not differ signifilcantly between the three groups (p>0.05). Mean time (SD) to first analgesia was 27(94) minutes in the piroxicam group, 16 (30) minutes in the diclofenac group and 62 (120) minutes in the piroxicam group. Six out oftwenty patients in the diclofenac group required further analgesia compared to nine out oftwenty in the other two drug groups. This difference was not significant. There were no reports of increased bleeding, bronchoconstriction, bleeding from the upper gastrointestinal tract, renal impairment or pain from the intra-muscular injection site in any of the groups. The administration of a non-steroidal anti-inflammatory drug to patients presenting for laparoscopic surgery reduces postoperative pain. There were no obvious differences between the agents used.
INTRODUCTION
Non-steroidal anti-inflammatory drugs [NSAIDS] are useful adjuncts to opioids for postoperative analgesia.' NSAIDS can provide similar analgesia to the opioids,2 but avoid the sedation, respiratory depression, nausea and vomiting caused by them. Many workers have shown that both diclofenac and ketorolac can reduce opioid requirements following major gynaecological and upper abdominal surgery.3 4'5 Diclofenac can provide similar analgesia to fentanyl following knee arthroscopy. 6 Unfortunately intramuscularly administered diclofenac has been associated with muscle damage,7 and due to increased reporting of severe bleeding and renal impairment, especially in the elderly8 the recommended dose of ketorolac has been reduced to a maximum daily dosage of 30mg. We compared the analgesic efficacy and incidence of side-effects of diclofenac, ketorolac and piroxicam, given intramuscularly after induction of anaesthesia, in patients undergoing inpatient gynaecological laparoscopic surgery.
METHODS
The study protocol was approved by the Regional Medical Ethics Committee and written informed consent was obtained from 60 ASA 1-2 (ie patients who are healthy or have a mild systemic illness) female patients scheduled for either in-patient diagnostic laparoscopy or laparoscopic sterilisation.
drugs, impaired renal function, asthma or on medication likely to interfere with the study results were excluded. We explained the use of the visual analogue scale (VAS) 0-10 at the preoperative visit. (The VAS was 10cm in length with 0 at the left end, representing "no pain" and 10 at the right end scoring "the worst pain imaginable"). Patients were premedicated with lorazepam 2mg by mouth 2 hours before surgery. Anaesthesia was induced with propofol 2mg/kg and fentanyl Imcg/ kg. Atracurium 0.5mg/kg was given to facilitate tracheal intubation and intraoperative ventilation. Anaesthesia was maintained with 1-1.5% isoflurane in 65% nitrous oxide in oxygen. At the end of the procedure neuromuscular blockade was reversed with neostigmine 2.5mg and glycopyrrolate 0.5mg. Following induction the patients were randomly allocated to receive a 3ml deep intra-muscular injection in the lateral compartment of the right thigh ofeither diclofenac 75mg (group D), ketorolac 30mg (group K ) or piroxicam 20mg (group P). The patients' age, height, and weight were recorded, and the interval from the end of surgery until the first request for analgesia was noted. Postoperative analgesia was prescribed in the form of either paracetamol lg or intra-muscular 'Cyclimorph 10' 0.01 ml/kg. This was administered to the patient by the recovery ward nurses who were unaware of the study drug given. Oral analgesia was administered if the patient's pain score was 3 or greater and and cyclimorph was given if the pain score was 5 or greater. The dose and timing of any postoperative analgesia was noted. Patients completed their VAS scores for pain on movement at the following times: on admission to recovery ward, at 1 hour, 2 hours, 4 hours and 24 hours after completion of surgery. They were also asked about the presence of musculoskeletal pain and pain from the NSAID injection site. For statistical analysis we used an independent samples Student's t-test for continuous variables, the Kruskal-Wallis test for VAS scores and Chisquare for categorical samples. A P value of < 0.05 was considered statistically significant.
RESULTS
Data were obtained from 60 patients and treatment groups were similar in respect ofage, height, weight and nature of surgery. There was no difference in the dosages of propofol or fentanyl between the three groups ( Table I ).
The VAS pain scores (Table II) 
